Citius Oncology, Inc. (NASDAQ: CTOR) — Healthcare · Share Price, Chart & Market Data
About: Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.88 (-10.30%)
CTORCitius Oncology, Inc.
Loading watchlist status…
Trade CTOR now
Citius Oncology, Inc. share price
CTOR price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:51 am GMT+0
CTOR price performance
-5.076%
5D
50.549%
1M
-18.787%
YTD
36.833%
1Y
CTOR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:51 am GMT+0
CTOR details
CTOR Market Signals